ロード中...
Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ
BACKGROUND: Endocrine therapy is commonly recommended in the adjuvant setting for patients as treatment for ductal carcinoma in situ (DCIS). However, it is unknown whether a neoadjuvant (preoperative) anti-estrogen approach to DCIS results in any biological change. This study was undertaken to inves...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2744704/ https://ncbi.nlm.nih.gov/pubmed/19689789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-9-285 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|